ZA938844B - Injectable composition. - Google Patents

Injectable composition.

Info

Publication number
ZA938844B
ZA938844B ZA938844A ZA938844A ZA938844B ZA 938844 B ZA938844 B ZA 938844B ZA 938844 A ZA938844 A ZA 938844A ZA 938844 A ZA938844 A ZA 938844A ZA 938844 B ZA938844 B ZA 938844B
Authority
ZA
South Africa
Prior art keywords
injectable composition
injectable
composition
Prior art date
Application number
ZA938844A
Other languages
English (en)
Inventor
David Carver
Timothy R Prout
Hernita Ewald
Original Assignee
Napro Biotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Napro Biotherapeutics Inc filed Critical Napro Biotherapeutics Inc
Publication of ZA938844B publication Critical patent/ZA938844B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA938844A 1992-11-27 1993-11-26 Injectable composition. ZA938844B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPL607492 1992-11-27

Publications (1)

Publication Number Publication Date
ZA938844B true ZA938844B (en) 1994-08-02

Family

ID=3776561

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA938844A ZA938844B (en) 1992-11-27 1993-11-26 Injectable composition.

Country Status (8)

Country Link
KR (1) KR100371062B1 (fr)
CN (2) CN1096673A (fr)
AU (1) AU5553894A (fr)
IL (2) IL107776A0 (fr)
IN (1) IN176188B (fr)
NZ (1) NZ258044A (fr)
WO (1) WO1994012198A1 (fr)
ZA (1) ZA938844B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69320206T2 (de) * 1992-11-27 1999-02-11 Napro Biotherapeutics Inc Paclitaxel enthaltende injizierbare zusammensetzung
TW406020B (en) * 1993-09-29 2000-09-21 Bristol Myers Squibb Co Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent
FR2710534B1 (fr) * 1994-09-28 1996-07-05 Bristol Myers Squibb Co Solvant de stabilisation, composition pharmaceutique le contenant, et son procédé de préparation.
NL9500340A (nl) * 1995-02-22 1996-10-01 Yew Tree Pharmaceuticals B V Gestabiliseerde paclitaxel-oplossing en farmaceutisch preparaat dat deze oplossing bevat.
US5686488A (en) * 1995-08-25 1997-11-11 Alcon Laboratories, Inc. Polyethoxylated castor oil products as anti-inflammatory agents
DE19536165A1 (de) * 1995-09-28 1997-04-03 Basf Ag Verfahren zur Reinigung von alkoxylierten Fetten
CN1209059A (zh) * 1995-12-21 1999-02-24 基因实验室技术有限公司 紫杉烷类组合物及方法
KR100191446B1 (ko) * 1996-05-02 1999-06-15 송영욱 파클리탁셀 함유 전신성 홍반성 낭창치료제
KR100330373B1 (ko) * 1996-05-28 2002-11-07 주식회사한국신약 탁솔을 함유한 주사용 약제 조성물
KR100358934B1 (ko) * 1996-09-13 2003-01-29 주식회사한국신약 탁솔을함유한주사용약제조성물
US6045808A (en) * 1997-01-31 2000-04-04 Pharmacia & Upjohn Company Method for removing high boiling solvents from drug formulations by vacuum drying
EP0998279B1 (fr) * 1997-05-30 2002-10-16 Man Woo Han Solution pharmaceutique injectable contenant du taxol
CN1101677C (zh) * 1997-05-30 2003-02-19 韩万愚 含有紫杉醇的药用注射溶液
BE1011216A3 (fr) * 1997-06-13 1999-06-01 Thissen En Abrege L T B Lab Forme pharmaceutique pour l'administration de paclitaxel, procede de preparation d'une composition de paclitaxel prete a l'emploi et utilisation de cette composition.
US6071952A (en) * 1998-12-02 2000-06-06 Mylan Pharmaceuticals, Inc. Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
WO2002043765A2 (fr) 2000-11-28 2002-06-06 Transform Pharmaceuticals, Inc. Formulations pharmaceutiques contenant du paclitaxel, ses derives et ses sels pharmaceutiquement acceptables
DE10115740A1 (de) * 2001-03-26 2002-10-02 Ulrich Speck Zubereitung für die Restenoseprophylaxe
KR100774366B1 (ko) 2001-09-10 2007-11-08 주식회사 중외제약 파클리탁셀 주사제 조성물
CZ294371B6 (cs) * 2002-06-10 2004-12-15 Pliva - Lachema, A. S. Stabilizovaná farmaceutická kompozice na bázi polyoxyethylovaného ricinového oleje a způsob její přípravy
HUE031505T2 (en) * 2002-06-26 2017-07-28 Syncore Biotechnology Co Ltd A method of producing a cationic liposomal composition comprising a lipophilic compound
EP1904052A4 (fr) * 2005-06-17 2008-12-10 Hospira Australia Pty Ltd Compositions pharmaceutiques liquides de docétaxel
TWI417114B (zh) 2005-08-31 2013-12-01 Abraxis Bioscience Llc 具有增強穩定性之弱水溶性藥物之組合物及其製備方法
CN101396354B (zh) * 2007-09-30 2010-12-01 江苏恒瑞医药股份有限公司 一种稳定的塔三烷类化合物液体组合物及其制备方法和其应用
CN101829051B (zh) * 2010-05-31 2012-09-12 南昌弘益科技有限公司 1’-乙酰氧基胡椒酚乙酸酯注射液
CN103432109B (zh) * 2013-09-01 2015-09-23 吴静 紫杉醇的药物组合物
US10561766B2 (en) * 2015-09-15 2020-02-18 W. L. Gore & Associates, Inc. Drug composition and coating

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
NZ224497A (en) * 1987-05-18 1990-04-26 Janssen Pharmaceutica Nv Pharmaceutical composition comprising flunarizine
US5157049A (en) * 1988-03-07 1992-10-20 The United States Of America As Represented By The Department Of Health & Human Services Method of treating cancers sensitive to treatment with water soluble derivatives of taxol
US4960790A (en) * 1989-03-09 1990-10-02 University Of Kansas Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
US5136060A (en) * 1989-11-14 1992-08-04 Florida State University Method for preparation of taxol using an oxazinone
TW223634B (fr) * 1991-03-18 1994-05-11 Kingston David G I
ATE180477T1 (de) * 1991-04-19 1999-06-15 Univ Mississippi Verfahren und zubereitungen zur isolierung von taxanen

Also Published As

Publication number Publication date
AU5553894A (en) 1994-06-22
IL107776A0 (en) 1994-02-27
NZ258044A (en) 1995-12-21
CN1047305C (zh) 1999-12-15
IL126178A0 (en) 1999-05-09
WO1994012198A1 (fr) 1994-06-09
KR100371062B1 (ko) 2003-04-21
AU667142B2 (en) 1996-03-07
CN1095266A (zh) 1994-11-23
IN176188B (fr) 1996-02-24
AU5196793A (en) 1994-06-09
CN1096673A (zh) 1994-12-28

Similar Documents

Publication Publication Date Title
EP0598412A3 (fr) Composition pour la protection de la peau.
ZA938844B (en) Injectable composition.
ZA939656B (en) Microvicidal compositions.
EP0621279A3 (fr) Compositions de siloxy-aluminoxane.
EP0597463A3 (en) Thermotherapiesonde.
EP0573056A3 (fr) Composition formant photoréserve à effet positif.
EP0580285A3 (fr) Auto-réenclencheurs.
EP0671929A4 (fr) Compositions.
IL106891A (en) ENR-NR composition
GB2268499B (en) Chipping-resistant composition
EP0600195A3 (en) Rubber composition.
EP0570884A3 (fr) Composition pour photoréserve positive.
EP0571988A3 (fr) Composition formant photoréserve positive.
PH30973A (en) Stabilized hypohalite composition.
PH31578A (en) Peroxygene bleach composition.
EP0668864A4 (fr) Biphenylmethylimidazopyridines substituees.
PH30815A (en) Composition.
EP0571989A3 (fr) Composition formant photoréserve positive.
EP0599191A3 (fr) Circuit de régulation de vitesse d'un moteur.
GB9223133D0 (en) Composition
CY2411B1 (en) Compositions.
EP0598320A3 (fr) Composition formant réserve positive.
EP0592354A3 (fr) Centrifugeuse à vide.
GB2272222B (en) Command-curable composition
EP0572763A3 (fr) Composition pour moulage.